Table: Kyowa Kirin -Q1 group results (IFRS)
May 10 (Reuters)-
Kyowa Kirin Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2022 Mar 31, 2021 Dec 31, 2022
LATEST YEAR-AGO COMPANY
RESULTS RESULT FORECAST
Sales 87.75 81.12 380.00
(+8.2 pct) (+4.9 pct) (+7.9 pct)
Operating
Pretax 18.72 16.16 66.00
(+15.8 pct) (+4.2 pct) (+9.9 pct)
Net 16.04 12.92 53.00
(+24.1 pct) (-6.7 pct) (+1.2 pct)
EPS Basic 29.85 yen 24.05 yen 98.64 yen
EPS Diluted 29.84 yen 24.04 yen
Ann Div 46.00 yen 48.00 yen
-Q2 Div 23.00 yen 24.00 yen
-Q4 Div 23.00 yen 24.00 yen
NOTE - Kyowa Kirin Co., Ltd..
(Figures are reported based on international accounting rules (IFRS).)
If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half
dividend and Q4 to the second-half dividend announced before a new corporate law in
2006 allowed companies to pay and report dividends on a quarterly basis.
*Net - represents Net profit attributable to owners of the parent company.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4151.T
Recent news on Kyowa Kirin
See all newsFactbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Brief: Kyowa Kirin Announces Agreement With US Administration To Reduce Treatment Costs For Americans
Table: Kyowa Kirin 6-MTH group results (IFRS)
Brief: Kyowa Kirin Says European Commission Approves Crysvita For Infants With X-Linked Hypophosphataemia